Skin Microbes May Offer Clues to Biological Aging and Frailty

Skin may offer researchers an unusually accessible window into the biology of aging, according to an article published in Science by Sasan Jalili of The Jackson Laboratory and Julia Oh, formerly of JAX and now at Duke University. The authors describe the skin as an ecosystem where microbes, immune cells, structural proteins and chemical signals interact as the body ages.

The focus is not on wrinkles or chronological age alone. Aging skin tends to become drier, heal more slowly and become more vulnerable to irritation, inflammation and infection. Its outer barrier loses ceramides and becomes less acidic, while some microbes associated with barrier function and immune regulation become less abundant. Other organisms linked with inflammation and tissue damage may increase.

Jalili argues that these microbial changes could be relevant to frailty, a decline in physiological resilience that can affect mobility, infection vulnerability, inflammation and cognition. The source reports that microbiome shifts appear to track frailty more closely than age in years in some observations. That could help explain why people of the same chronological age can have substantially different levels of physical function and resilience.

The evidence described remains primarily observational and correlational. The researchers have not established which microbial functions contribute to aging biology, or whether microbiome changes cause deterioration in skin immunity and repair. Jalili characterizes aged skin immunity as “recalibrated,” rather than simply weaker, raising the question of whether microbial changes influence the balance between repair and chronic inflammation.

Skin’s accessibility could make it useful for repeated monitoring. Surface swabs can collect microbes but offer only a partial view, while biopsies provide deeper information at the cost of being invasive and impractical for routine sampling, particularly in older adults. Researchers therefore hope that skin measurements might eventually help identify signs of frailty before clinical decline becomes apparent, although clinicians want evidence that such measurements would change patient care.

To address the sampling challenge, Jalili is collaborating with researchers and clinicians at the UConn Center on Aging to test a microneedle patch developed with scientists at MIT. About the size of a small adhesive bandage, the patch uses tiny projections to access upper skin layers and collect information from immune cells in the tissue. The technology was initially developed during Jalili’s postdoctoral training at MIT and later refined at JAX with UMass Chan collaborators as it moved from mouse models toward clinical application.

Work on the patch was published in Nature Biomedical Engineering in March, according to the source. The current goal is not to reverse aging, but to determine whether certain functions lost in aged skin can be restored and whether microbes, immune cells or their interactions help explain differences in resilience.